Red biotechnology in Germany Viola Eckelt with most of the leading

with most of the leading laboratories worldwide being represented

most existing scientific software is designed in an ad hoc way

dass sämtliche Entscheidungen im Finanzierungs- und Investitionsbereich ein betriebswirtschaftlich sinnvolles Abwägen von Chancen und Risiken erfordern

En minnesbok över den rasande kampen mellan människan och havet

Red biotechnology in Germany Viola Eckelt with most of the leadingStudienarbeit aus dem Jahr 2010 im Fachbereich BWL Sonstiges, Note: 1,9, Stuttgart Institute of Management and Technology, Veranstaltung: International Management, Sprache: Deutsch, Abstract: The entrance of biotechnology into medicine, especially driven by new genetic techniques, has led to promising new markets. Biotech companies are spending extraordinary sums in R&D before new technologies generate a return on the investment. In Germany alone